No. | Authors, year | Test group | Control group | Duration | Primary outcome | Secondary outcome | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TCMs | Behavioral interventions | Pharmacological interventions | Behavioral interventions | TCM syndrome score | Adverse reactions | Radiological response | Liver function | Body weight | Blood sugar | Blood lipid | Others | |||
1 | Wu et al., 2020 [43] | Jianpi Qingzhi prescription | Diet and exercise | Polyene Phosphatidylcholine capsules | Diet and exercise | 12 weeks | Yes | N/A | BU, CT | ALT, AST, GGT | N/A | FBG, FINs, HOMA-IR, | TG, TC | DAO, LPS, d-lactic acid, Claudin-1, Claudin-4 |
2 | Lyv et al., 2020 [47] | Shenge formula | Diet and exercise | N/A | Diet and exercise | 6 months | Yes | N/A | N/A | ALT, AST | N/A | N/A | TG, TC | N/A |
3 | Yang et al., 2019 [59] | Yanggan Jieyu granule | Diet and exercise | Polyene phosphatidylcholine capsules | Diet and exercise | 24 weeks | Yes | N/A | CT | ALT, AST, GGT | N/A | N/A | TG, TC, LDL-C | N/A |
4 | Yang et al., 2019 [97] | Qinjiang Baoling decoction | Diet and exercise | N/A | Diet and exercise | 3 months | Yes | N/A | BU, CT | ALT, GGT | BMI | HOMA-IR | TC, HDL-C | N/A |
5 | Li et al., 2018 [62] | Qutan Huoxue decoction | N/A | Silibinin capsules | N/A | 24 weeks | Yes | Yes | CT | ALT, AST, GGT | N/A | N/A | TG, TC | N/A |
6 | Chen et al., 2017 [98] | Shuangqing granule | Diet and exercise | Xuezhikang capsules | Diet and exercise | 12 weeks | Yes | N/A | BU | AST, ALT | N/A | N/A | TG, TC, HDL-C, LDL-C | N/A |
7 | Hu et al., 2017 [31] | Jianpishugan and Huoxuehuatan formula | Diet and exercise | Polyene Phosphatidylcholine capsules | Diet and exercise | 3 months | Yes | Yes | BU | ALT, AST, GGT | BMI | N/A | TG, TC, HDL-C, LDL-C | N/A |
8 | Jiang et al., 2017 [41] | Dahuang Lidan capsule | Diet and exercise | Polyene Phosphatidylcholine capsules | Diet and exercise | 12 weeks | Yes | Yes | BU | ALT, AST, GGT | N/A | N/A | TG, TC, HDL-C, LDL-C | N/A |
9 | Yang et al.,2017 [53] | Cigu Xiaozhi capsule | Diet and exercise | Polyene Phosphatidylcholine capsules | Diet and exercise | 8 weeks | Yes | N/A | BU | ALT, AST, ALP, GGT | BMI | N/A | TG, TC, HDL-C, LDL-C | N/A |
10 | Jeong et al., 2017 [28] | Test group 1—HL tablet—high dose | N/A | Placebo | N/A | 12 weeks | N/A | Yes | N/A | ALT, AST | BMI | HOMA-IR | TG, TC, HDL-C, LDL-C | MRS, free fatty acid |
Test group 2—HL tablet—low dose | N/A | Placebo | N/A | 12 weeks | N/A | |||||||||
11 | Sun et al., 2017 [68] | Jianpi Qushi prescription | Diet and exercise | N/A | Diet and exercise | 3 months | Yes | N/A | BU | ALT, AST | N/A | FPG, FINs | TG, TC | N/A |
12 | Niu 2016 [48] | Shugan Jianpi Huatan decoction | Diet and exercise | Atorvastatin calcium tablets | Diet and exercise | 3 months | Yes | N/A | N/A | ALT, AST | N/A | FBG, FNIs, HOMA-IR | TG, TC | N/A |
13 | Zhang et al., 2016 [99] | Yiqi Qizhu decoction | Diet and exercise | Polyene phosphatidylcholine capsules | Diet and exercise | 3 months | Yes | Yes | BU | ALT, AST, GGT | N/A | N/A | TG, TC | N/A |
14 | Zhang et al., 2016 [34] | Jiang Zhi granules | N/A | Ursodeoxycholic acid capsules | N/A | 24 weeks | Yes | N/A | BU | N/A | N/A | N/A | N/A | N/A |
15 | Qi et al., 2016 [63] | Jiangpi Shugan Huoxue Huatan decoction | Diet and exercise | Silibinin capsules | N/A | 3 months | Yes | N/A | BU | ALT, AST, GGT | N/A | N/A | TG, TC, HDL-C, LDL-C | N/A |
16 | Tan et al., 2016 [100] | Shugan Jianpi decoction | Diet and exercise | Pioglitazone | N/A | 3 months | Yes | Yes | BU | ALT, AST | BMI, WHR | FBG, FNIs, HOMA-IR | TG, TC | N/A |
17 | Yu et al., 2016 [69] | Qinggan Jiangzhi decoction | Diet and exercise | Polyene phosphatidylcholine tablet and Dangfei Liganning capsule | Diet and exercise | 24 weeks | Yes | N/A | BU | ALT, AST, GGT | BMI, BM | N/A | TG, TC | N/A |
18 | Yin et al., 2016 [35] | Danxia Zhifang decoction; simulated Zhiganxiao capsule | N/A | Qianggan capsule | N/A | 3 months | Yes | N/A | BU, CT | ALT, AST, GGT,TB, DB, TP, ALB, A/G, | N/A | N/A | TG, TC | N/A |
19 | Zhu 2015 [33] | Qingdan Jiangzhi decoction | Diet and exercise | Tiopronin enteric-coated tablets | Diet and exercise | 12 weeks | Yes | N/A | BU | N/A | N/A | N/A | N/A | N/A |
20 | Li 2015 [64] | Huatan Lishi Huoxue granule combined granule decoction | Diet and exercise | Polyene phosphatidylcholine capsules | Diet and exercise | 3 months | Yes | Yes | CT | ALT | N/A | N/A | TG | N/A |
21 | Chen et al., 2015 [101] | Zaozhu Yinchen decoction | N/A | Silymarin meglumine tablet | N/A | 2 months | Yes | Yes | BU | ALT, AST | N/A | N/A | TG, TC | N/A |
22 | Yu et al., 2015 [52] | Tiaogan Lipi recipe | Diet and exercise | Placebo | Diet and exercise | 12 weeks | Yes | Yes | CT | ALT, AST, GGT | N/A | N/A | TG, TC | N/A |
23 | Li et al., 2015 [58] | Qinghua decoction | Diet and exercise | N/A | Diet and exercise | 6 months | Yes | N/A | BU | ALT, AST, GGT, TB | BMI, WHR | N/A | TG, TC | N/A |
24 | Liu et al., 2014 [49] | Heze lipid-lowering oral liquid | N/A | Polyene phosphatidylcholine capsules | N/A | 4 months | Yes | N/A | CT | ALP, AST, GGT, GLP, ALB | BMI | N/A | TG, TC, HDL-C, LDL-C | N/A |
25 | Liu et al., 2014 [50] | Ruangan Jiangzhi capsule | Diet and exercise | Polyene phosphatidylcholine capsules | Diet and exercise | 12 weeks | Yes | Yes | BU | ALT, GGT | N/A | N/A | TG, TC | N/A |
26 | Li et al., 2014 [51] | Jianpi Shugan recipe | Diet and exercise | Polyene phosphatidylcholine capsules | Diet and exercise | 3 months | Yes | Yes | CT | ALT | N/A | N/A | N/A | N/A |
27 | Zhu et al., 2014 [102] | Zhigan pill | N/A | Placebo | N/A | 3 months | Yes | N/A | BU | N/A | N/A | N/A | N/A | N/A |
28 | Wen et al., 2014 [60] | Jiangan Xiaozhi granule | Diet and exercise | Hedan tablet | Diet and exercise | 3 months | Yes | Yes | CT | ALT, AST, GGT | N/A | N/A | TG, TC, HDL-C, LDL-C | N/A |
29 | Deng, 2013 [103] | Jiangan Sanqing decoction | N/A | Polyene Phosphatidylcholine capsules | N/A | 3 months | Yes | N/A | BU | ALT, AST | N/A | N/A | TG, TC | N/A |
30 | Li et al., 2013 [54] | Jianpi Huatan Zhuyu prescription | N/A | Qianggan capsule | N/A | 3 months | Yes | Yes | BU | ALT, AST, GGT | N/A | N/A | TG, TC | N/A |
31 | Song et al., 2013 [104] | Modified Linggui Zhugan decoction | N/A | Polyene phosphatidylcholine capsules | N/A | 3 months | Yes | N/A | CT | ALT, AST | N/A | N/A | TG, TC | N/A |
32 | Li et al., 2013 [42] | Qushi Huayu decoction | N/A | Polyene phosphatidylcholine capsules | N/A | 24 weeks | Yes | Yes | BU | ALT, AST | N/A | N/A | TG, TC, HDL-C, LDL-C | N/A |
33 | Wong et al., 2013 [26] | Phyllanthus urinaria | Diet and exercise | Placebo | Diet and exercise | 24 weeks | N/A | Yes | N/A | ALT, AST | N/A | HbA1 | HDL-C, LDL-C | N/A |
34 | Pan et al., 2013 [27] | Jiang Zhi granule | Diet and exercise | Placebo | Diet and exercise | 24 weeks | N/A | Yes | CT | N/A | BMI | N/A | TG, TC | N/A |
35 | Chen et al., 2012 [45] | Jindanwang mixture | Diet | Ursodeoxycholic acid capsules | Diet | 24 weeks | Yes | N/A | BU, CT | ALT, AST | N/A | N/A | TG, TC | N/A |
36 | Zhao et al., 2012 [30] | Huatan Xiezhuo recipe | Diet and exercise | Polyene phosphatidylcholine capsules | Diet and exercise | 3 months | Yes | Yes | N/A | ALT | BMI | N/A | TG | N/A |
37 | Wang et al., 2012 [65] | Yigan Jiedu decoction | Diet and exercise | Silymarin | Diet and exercise | 2 months | Yes | N/A | N/A | ALT, AST, GGT | N/A | N/A | TG, TC | N/A |
38 | Pei et al., 2012 [70] | Qinggan Huatan Huoxue recipe | Diet and exercise | Danning tablet | Diet and exercise | 3 months | Yes | Yes | BU | ALT, AST, GGT | BMI | FBG, FNIs, HOMA-IR | TG, TC, HDL-C, LDL-C | N/A |
39 | Wu 2012 [83] | Jianpi Huatan formula | N/A | Vitamin E | N/A | 3 months | N/A | Yes | BU | ALT, AST | N/A | FBG, FNIs, HOMA-IR | TG, TC, HDL-C, LDL-C | N/A |
40 | Tong et al., 2011 [105] | Jiedu Jianpi Tongluo decoction | N/A | Silibinin capsules | N/A | 12 weeks | Yes | Yes | BU | ALT, AST, GGT, TB | N/A | N/A | TG, TC, HDL-C, LDL-C | N/A |
41 | Zhang et al., 2011 [66] | Kangzhi decoction | N/A | Tiopronin enteric-coated tablets | N/A | 6 months | Yes | Yes | BU, CT | ALT, AST, GGT | N/A | N/A | TG, TC | N/A |
42 | Gu et al., 2011 [61] | Zhigan capsule | Diet and exercise | Polyene phosphatidylcholine capsules | Diet and exercise | 3 months | Yes | Yes | BU | ALT, AST, GGT | BMI | FBG | TG, TC, LDL-C | N/A |
43 | Zhao et al., 2010 [46] | Qiyin tea | N/A | Polyene phosphatidylcholine capsules | N/A | 2 months | Yes | N/A | BU | AST, ALP, AST, GGT | N/A | N/A | TG, TC | N/A |
44 | Ding et al., 2010 [88] | Pingganjian decoction | Diet and exercise | Silymarin, Ultivarietas Oryzae Saltlicae Et Monasci | Diet and exercise | 3 months | Yes | Yes | CT | ALT, AST | BMI,WHR | FBG, FNIs, HOMA-IR | TG, TC | N/A |
45 | Pan et al., 2010 [32] | Tiaozhiji granules | N/A | Hedan tablet | N/A | 3 months | Yes | Yes | BU, CT | ALT, AST, GGT | N/A | N/A | TG, TC | N/A |
46 | Liu et al., 2008 [67] | Qiyin granules | Diet and exercise | Polyene phosphatidylcholine capsules | Diet and exercise | 2 months | Yes | N/A | BU | ALT, AST | N/A | N/A | TG, TC | N/A |
47 | Ji et al., 2008 [25] | Danning tablet | Diet and exercise | Ursodeoxycholic acid tablet | Diet and exercise | 24 weeks | Yes | Yes | CT | ALT, AST, GGT | BMI | N/A | TG, TC | N/A |
48 | Chen et al., 2008 [29] | Xiaoyao San decoction and Danggui Shaoyao San decoction | Diet | Anethol trithione | Diet | 3 months | Yes | N/A | BU | ALT, AST | N/A | N/A | TG, TC | N/A |
49 | Lou et al., 2008 [44] | Yiqi Sanju formula | N/A | Placebo | N/A | 3 months | Yes | Yes | CT | ALT, AST | BMI | FBG, FNIs, HOMA-IR | TG, TC, HDL-C, LDL-C | hs-CRP, TNF-α |
50 | Li et al., 2007 [55] | Jianpi Bushen decoction | N/A | Silibinin | N/A | 8 weeks | Yes | Yes | BU | ALT, AST, GGT,TB | N/A | N/A | TG, TC, HDL-C, LDL-C | N/A |
51 | Yang et al., 2007 [56] | Yigan Jiangzhi capsule | N/A | Dongbao Gantai tablet | N/A | 3 months | N/A | N/A | BU, CT | ALT, AST, GGT | N/A | N/A | TG, TC, HDL-C, LDL-C | N/A |
52 | Gu et al., 2007 [24] | Tiaozhi Yanggan decoction | Diet and exercise | Thiola tablet | Diet and exercise | 12 weeks | Yes | Yes | N/A | ALT, AST, GGT | N/A | N/A | TG, TC, HDL-C, LDL-C | N/A |
53 | Chen et al., 2006 [57] | Qianggan capsule | Diet and exercise | Tiopronin | Diet and exercise | 3 months | N/A | N/A | BU | ALT, GGT | N/A | N/A | TG | N/A |
No. | Authors, year | Overall findings | ||||
---|---|---|---|---|---|---|
Efficacy | Safety | |||||
Overall efficacy rate of test group | Overall efficacy rate of control group | Difference between the 2 groups | Non-serious | Serious | ||
1 | Wu et al., 2020 [43] | 93.33% | 80.00% | Test group (P < 0.05) | N/A | N/A |
2 | Lyv et al., 2020 [47] | 100.00% | 48.39% | Test group (P < 0.05) | N/A | N/A |
3 | Yang et al., 2019 [59] | 86.67% | 73.33% | Test group (P < 0.01) | N/A | N/A |
4 | Yang et al., 2019 [97] | 64.00% | 52.00% | Test group (P < 0.05) | N/A | N/A |
5 | Li et al., 2018 [62] | 84.13% | 56.45% | Test group (P < 0.01) | None | None |
6 | Chen et al., 2017 [98] | 89.7% | 84.0% | Test group (P < 0.05) | N/A | N/A |
7 | Hu et al., 2017 [31] | 94.28% | 77.14% | Test group (P < 0.01) | None | None |
8 | Jiang et al., 2017 [41] | Specific outcome readings | Specific outcome readings | Test group (P < 0.01) | ADR1 | None |
9 | Yang et al., 2017 [53] | 93.02% | 68.18% | Test group (P < 0.01) | N/A | N/A |
10 | Jeong et al., 2017 [28] | Specific outcome readings | Specific outcome readings | High dose group (P = 0.033) | ADR2 | None |
Specific outcome readings | Specific outcome readings | Low dose group (P = 0.386) | ||||
11 | Sun et al., 2017 [68] | 93.33% | 61.67% | Test group (P < 0.01) | N/A | N/A |
12 | Niu 2016 [48] | 95.00% | 76.60% | Test group (P < 0.05) | N/A | N/A |
13 | Zhang et al., 2016 [99] | 92.31% | 78.85% | Test group (P < 0.05) | None | None |
14 | Zhang et al., 2016 [34] | 33.80% | 23.39% | Test group (P < 0.05) | N/A | N/A |
15 | Qi et al., 2016 [63] | 93.30% | 62.20% | Test group (P < 0.05) | N/A | N/A |
16 | Tan et al., 2016 [100] | 87.23% | 71.11% | Test group (P < 0.05) | ADR3 | None |
17 | Yu et al., 2016 [69] | Specific outcome readings | Specific outcome readings | Test group (P < 0.01) | N/A | N/A |
18 | Yin et al., 2016 [35] | 81.63% | 62.5% | Test group (P < 0.05) | N/A | N/A |
19 | Zhu, 2015 [33] | Specific outcome readings | Specific outcome readings | Test group (P < 0.05) | N/A | N/A |
20 | Li, 2015 [64] | 98.10% | 80.80% | Test group (P < 0.05) | None | None |
21 | Chen et al., 2015 [101] | 87.50% | 73.68% | Test group (P < 0.05) | None | None |
22 | Yu et al., 2015[52] | Specific outcome readings | Specific outcome readings | Test group (P < 0.05) | None | None |
23 | Li et al., 2015 [58] | 58.33% | 30.51% | Test group (P < 0.01) | N/A | N/A |
24 | Liu et al., 2014 [49] | 52.94% | 29.09% | Test group (P < 0.05) | N/A | N/A |
25 | Liu et al., 2014 [50] | 91.67% | 56.67% | Test group (P < 0.05) | ADR4 | None |
26 | Li et al., 2014 [51] | 84.09% | 75.00% | Test group (P < 0.05) | ADR5 | None |
27 | Zhu et al., 2014 [102] | 85.83% | 63.16% | Test group (P < 0.05) | N/A | N/A |
28 | Wen et al., 2014 [60] | 78.40% | 55.60% | Test group (P < 0.05) | None | None |
29 | Deng, 2013 [103] | 90.00% | 70.00% | Test group (P < 0.05) | N/A | N/A |
30 | Li et al., 2013 [54] | 86.60% | 66.60% | Test group (P < 0.05) | None | None |
31 | Song et al., 2013 [104] | 91.70% | 69.00% | Test group (P < 0.01) | N/A | N/A |
32 | Li et al., 2013 [42] | specific outcome readings | specific outcome readings | Test group (P < 0.01) | ADR6 | None |
33 | Wong et al., 2013 [26] | Specific outcome readings | Specific outcome readings | Not siginificant | ADR7 | ADR8 |
34 | Pan et al., 2013 [27] | Specific outcome readings | Specific outcome readings | Test group (P < 0.05) | ADR9 | None |
35 | Chen et al., 2012 [45] | 94.00% | 92.00% | No siginificant differences (P > 0.05) | N/A | N/A |
36 | Zhao et al., 2012 [30] | Specific outcome readings | Specific outcome readings | Test group (P < 0.01) | None | None |
37 | Wang et al., 2012 [65] | 75.56% | 51.11% | Test group (P < 0.01) | N/A | N/A |
38 | Pei et al., 2012 [70] | 87.20% | 73.60% | Test group (P < 0.05) | ADR10 | None |
39 | Wu 2012 [83] | 83.30% | 46.67% | Test group (P < 0.05) | None | None |
40 | Tong et al., 2011 [105] | 86.67% | 76.09% | Test group (P < 0.05) | None | None |
41 | Zhang et al., 2011 [66] | 86.90% | 67.70% | Test group (P < 0.05) | None | None |
42 | Gu et al., 2011 [61] | 90.00% | 72.00% | Test group (P < 0.05) | ADR11 | None |
43 | Zhao et al., 2010 [46] | 87.60% | 83.90% | No siginificant differences (p = 0.873) | N/A | N/A |
44 | Ding et al., 2010 [88] | 83.33% | 45.10% | Test group (P < 0.05) | ADR12 | None |
45 | Pan et al., 2010 [32] | Specific outcome readings | Specific outcome readings | Test group (P < 0.05) | None | None |
46 | Liu et al., 2008 [67] | Specific outcome readings | Specific outcome readings | Test group (P < 0.05) | N/A | N/A |
47 | Ji et al., 2008 [25] | Specific outcome readings | Specific outcome readings | Test group (P < 0.05) | ADR13 | None |
48 | Chen et al., 2008 [29] | 96.77% | 83.87% | Test group (P < 0.05) | N/A | N/A |
49 | Lou et al., 2008 [44] | 94.87% | 32.14% | Test group (P < 0.01) | ADR14 | None |
50 | Li et al., 2007 [55] | 87.23% | 71.11% | Test group (P < 0.05) | None | None |
51 | Yang et al., 2007 [56] | 88.20% | 71.70% | Test group (P < 0.05) | N/A | N/A |
52 | Gu et al., 2007 [24] | 81.19% | 68.97% | Test group (P < 0.05) | ADR15 | None |
53 | Chen et al., 2006 [57] | 79.69% | 62.07% | Test group (P < 0.05) | N/A | N/A |